LY3938577
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for LY3938577, covering 2024-07-24 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin [Phase 2]